查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| MXL MaxLinear Inc. Common Stock | 1.75 2026-12-31 | 1.72 – 1.78 | 9 | +30.31% | +30.84% | +30.36% | 10 / 0 | $738.02M |
| IMAX Imax Corporation Common Stock | 1.82 2026-12-31 | 1.69 – 2.12 | 8 | +9.25% | +7.94% | +7.70% | 1 / 2 | $444.18M |
| MIAX Miami International Holdings Inc. Common Stock | 1.63 2026-12-31 | 1.45 – 1.74 | 7 | +0.63% | +5.12% | +12.40% | 4 / 0 | $538.43M |
| BAX Baxter International Inc. Common Stock | 1.99 2026-12-31 | 1.95 – 2.05 | 7 | +4.00% | +4.07% | +4.05% | 6 / 2 | $11.46B |
| AXTA Axalta Coating Systems Ltd. Common Shares | 2.65 2026-12-31 | 2.57 – 2.71 | 16 | +1.66% | +2.22% | +2.73% | 2 / 0 | $5.24B |
| KMX CarMax Inc | 2.73 2027-02-28 | 2.46 – 3.16 | 14 | +0.92% | +0.98% | +16.23% | 8 / 1 | $27.09B |
| AXON Axon Enterprise Inc. Common Stock | 7.72 2026-12-31 | 6.7 – 9.39 | 20 | 0.00% | +0.46% | -0.51% | 10 / 9 | $3.66B |
| BNS Bank Nova Scotia Halifax Pfd 3 Ordinary Shares | 8.3 2026-10-31 | 8.15 – 8.53 | 12 | -0.00% | +0.10% | +1.34% | 12 / 1 | $39.63B |
| ACLS Axcelis Technologies Inc. Common Stock | 3.83 2026-12-31 | 3.68 – 4 | 5 | 0.00% | 0.00% | +5.27% | 1 / 0 | $843.92M |
| AXTI AXT Inc Common Stock | 0.3 2026-12-31 | 0.23 – 0.38 | 5 | 0.00% | 0.00% | — | 0 / 1 | $143.08M |
| RMAX RE/MAX Holdings Inc. Class A Common Stock | 1.29 2026-12-31 | 1.23 – 1.35 | 3 | 0.00% | 0.00% | -1.10% | 2 / 0 | $295.15M |
| AXP American Express Company Common Stock | 17.65 2026-12-31 | 17.04 – 18.52 | 28 | -0.35% | -0.25% | +0.32% | 5 / 4 | $79.48B |
| EFX Equifax Inc. Common Stock | 8.57 2026-12-31 | 8.19 – 8.79 | 24 | -0.30% | -0.41% | -0.67% | 1 / 1 | $6.75B |
| AX Axos Financial Inc. Common Stock | 9.61 2027-06-30 | 9.47 – 9.8 | 6 | -0.64% | -0.60% | -1.24% | 1 / 1 | $1.61B |
| PAX Patria Investments Limited Class A Common Shares | 1.36 2026-12-31 | 1.33 – 1.4 | 5 | -0.44% | -0.77% | -5.75% | 0 / 5 | $425.72M |
| HZO MarineMax Inc. (FL) Common Stock | 0.71 2026-09-30 | 0.65 – 0.84 | 9 | -3.80% | -1.29% | -4.33% | 3 / 4 | $2.21B |
| MKTX MarketAxess Holdings Inc. Common Stock | 7.94 2026-12-31 | 7.4 – 8.27 | 10 | +0.17% | -1.70% | -3.77% | 0 / 2 | $892.78M |
| AXS Axis Capital Holdings Limited Common Stock | 12.3 2026-12-31 | 11.97 – 12.9 | 6 | -5.81% | -7.00% | -7.60% | 1 / 1 | $6.34B |
| AXGN Axogen Inc. Common Stock | 0.44 2026-12-31 | 0.33 – 0.49 | 7 | -9.94% | -9.94% | -9.94% | 1 / 4 | $279.53M |
| ABVX Abivax SA American Depositary Shares | -3.58 2026-12-31 | -4.24 – -2.5 | 6 | — | — | — | 3 / 1 | $74.92M |
| AXSM Axsome Therapeutics Inc. Common Stock | -1.73 2026-12-31 | -3.35 – 1.3 | 10 | — | — | — | 1 / 5 | $978.93M |
| BCAX Bicara Therapeutics Inc. Common Stock | -3.48 2026-12-31 | -4.08 – -2.52 | 13 | — | — | — | 0 / 11 | $0 |
| EPRX Eupraxia Pharmaceuticals Inc. Common Stock | -0.98 2026-12-31 | -1.17 – -0.78 | 8 | — | — | — | 0 / 5 | $0 |
| GLXY Galaxy Digital Inc. Class A Common Stock | -0.55 2026-12-31 | -1.41 – 0.8 | 14 | — | — | — | 0 / 1 | $60.15B |
| MXCT MaxCyte Inc. Common Stock | -0.28 2026-12-31 | -0.29 – -0.26 | 4 | — | — | — | 1 / 1 | $31.08M |
| NVAX Novavax Inc. Common Stock | -0.47 2026-12-31 | -1.38 – 0.52 | 9 | — | — | — | 1 / 6 | $409.97M |
| PCVX Vaxcyte Inc. Common Stock | -8.48 2026-12-31 | -9.81 – -6.22 | 7 | — | — | — | 0 / 0 | $0 |
| PRAX Praxis Precision Medicines Inc. Common Stock | -15.32 2026-12-31 | -22.94 – -13.25 | 16 | — | — | — | 1 / 3 | $2.29M |
| REAX The Real Brokerage Inc. Common Shares | -0.02 2026-12-31 | -0.03 – 0.01 | 4 | — | — | — | 0 / 2 | $2.39B |
| SNDX Syndax Pharmaceuticals Inc. Common Stock | -1.6 2026-12-31 | -2.2 – -1.16 | 11 | — | — | — | 1 / 1 | $344.78M |
| STXS Stereotaxis Inc. Common Stock | -0.19 2026-12-31 | -0.23 – -0.17 | 3 | — | — | — | 0 / 1 | $39.4M |
| TENX Tenax Therapeutics Inc. Common Stock | -1.44 2026-12-31 | -1.7 – -1.2 | 8 | — | — | — | 0 / 0 | $0 |
| TRAX First Tracks Biotherapeutics Inc. Ordinary Shares | -3.6 2026-12-31 | -4.17 – -3.3 | 8 | — | — | — | 0 / 1 | $0 |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。